HOME >> BIOLOGY >> NEWS
Cuttlefish masters of disguise despite colorblindness

WOODS HOLE, MA--Cuttlefish are wizards of camouflage. Adept at blending in with their surroundings, cuttlefish are known to have a diverse range of body patterns and can switch between them almost instantaneously. New research from MBL Marine Resources scientists, to appear in the May 2006 issue of the journal Vision Research, confirms that while these masters of disguise change their appearance based on visual cues, they do so while being completely colorblind.

While previous research has reported cuttlefish colorblindness, MBL Research Associate Lydia Mthger and her colleagues in Roger Hanlon's laboratory approached the problem in more depth and with a new behavioral assay. The researchers tested cuttlefish (Sepia officinalis) color perception through observing the animal's behavioral response to a series of checkerboard patterned substrates of various colors and brightnesses.

They found that the animals did not respond to the checkerboard pattern when placed on substrates whose color intensities were matched to the Sepia visual system, suggesting that these checkerboards appeared to their eyes as uniform backgrounds. However, their results showed that cuttlefish were able to detect contrast differences of at least 15%, which Mthger and her colleagues suspect might be a critical factor in uncovering what determines camouflage patterning in cuttlefish.

Despite these results, the vexing question of how cuttlefish master the task of camouflage in low-contrast, color-rich environments such as those found at shallow depths of water, remains to be answered. Mthger and her colleagues are currently looking at cuttlefish contrast sensitivity in more detail. "Our result that cuttlefish are able to detect contrast differences of at least 15%, is only an upper limit," says Mthger. "It's certainly not the contrast threshold, which we would like to know. It seems that cuttlefish camouflage themselves by matching intensities of objects in the environment
'"/>

Contact: Gina Hebert
ghebert@mbl.edu
508-289-7725
Marine Biological Laboratory
18-Apr-2006


Page: 1 2

Related biology news :

1. New data reveal pregnancies exposed to accutane despite risk management program
2. Penn researchers report that gene therapy awakens the brain despite blindness from birth
3. Treatment disconnect in kidney cancer: Rising mortality despite more small tumors, more surgery
4. Creative economy grows despite large population growth of creative people
5. Chewing up a key regulator of fat synthesis keeps mice lean despite a high-fat diet
6. Rhinos clinging to survival in the heart of Borneo, despite poaching
7. Genetic testing still smart choice, despite uncertainties
8. Low-income pregnant Latinas drink despite universal alcohol-warning messages
9. NSAID drug protects against intestinal tumors in mice, despite poor diet and gene losses
10. Study by US, Hebrew University scientists sheds light on how bacteria persist despite antibiotics
11. Mice thrive despite massive genetic makeover

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cuttlefish masters disguise despite colorblindness

(Date:7/13/2015)... SAN JOSE, Calif. , July 13, 2015 ... the leading developer of human interface solutions, today ... second generation touch and display driver integration (TDDI) ... solution is the first to combine Synaptics , ... expertise with proven display driver technology developed in ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
(Date:7/29/2015)... 2015 Research and ... of the "Global Biosimilars Market, 2015 - ... The Global Biosimilars Market, 2015 - 2025, report ... biosimilars market. With the blockbuster biologics losing patent ... biosimilars are being viewed as viable substitutes to ...
(Date:7/29/2015)... July 29, 2015  Pfenex Inc. (NYSE MKT: PFNX) ... will be released on Thursday, August 13, 2015, before ... Pfenex management will host a conference call to discuss ... press release outlining the financial results and business update ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) and ...
(Date:7/29/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ... an optimized Erk inhibitor molecule for development, thus ... a new class of potential cancer therapies. ... target for therapeutic intervention in cancer. Recently approved ... for B-Raf and Mek inhibitors. Erk inhibitors may ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: